Fig. 4

Comparative analysis of efficacy and safety outcomes of ICS/LABA combinations during a 1-year post-index period. DPI, dry powder inhaler; ED, emergency-department; ICS, inhaled corticosteroid; LABA, long-acting \(\:\beta\:\)2 agonist; MDI, metered dose inhaler